- Home
- MNDO vs TENX Comparison
MNDO vs TENX Comparison
Compare MNDO & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- TENX
- Stock Information
- Founded
- MNDO 1995
- TENX 1967
- Country
- MNDO Israel
- TENX United States
- Employees
- MNDO N/A
- TENX N/A
- Industry
- MNDO EDP Services
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- MNDO Technology
- TENX Health Care
- Exchange
- MNDO Nasdaq
- TENX Nasdaq
- Market Cap
- MNDO 26.5M
- TENX 25.8M
- IPO Year
- MNDO 2000
- TENX N/A
- Fundamental
- Price
- MNDO $1.33
- TENX $5.91
- Analyst Decision
- MNDO
- TENX Strong Buy
- Analyst Count
- MNDO 0
- TENX 3
- Target Price
- MNDO N/A
- TENX $16.00
- AVG Volume (30 Days)
- MNDO 30.3K
- TENX 23.2K
- Earning Date
- MNDO 08-19-2025
- TENX 08-19-2025
- Dividend Yield
- MNDO 16.54%
- TENX N/A
- EPS Growth
- MNDO N/A
- TENX N/A
- EPS
- MNDO 0.17
- TENX N/A
- Revenue
- MNDO $20,677,000.00
- TENX N/A
- Revenue This Year
- MNDO N/A
- TENX N/A
- Revenue Next Year
- MNDO N/A
- TENX N/A
- P/E Ratio
- MNDO $7.82
- TENX N/A
- Revenue Growth
- MNDO N/A
- TENX N/A
- 52 Week Low
- MNDO $1.29
- TENX $3.25
- 52 Week High
- MNDO $2.13
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- MNDO 37.92
- TENX 43.41
- Support Level
- MNDO $1.29
- TENX $5.80
- Resistance Level
- MNDO $1.35
- TENX $6.25
- Average True Range (ATR)
- MNDO 0.04
- TENX 0.26
- MACD
- MNDO -0.01
- TENX -0.02
- Stochastic Oscillator
- MNDO 19.05
- TENX 26.90
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.